by Mary Ann Liebert, Inc Credit: Unsplash/CC0 Public Domain A study in the journal Diabetes Technology & Therapeutics (DTT) concludes that inhaled technosphere insulin (TI-Afrezza) should be considered as an option for individuals with type 1 diabetes who want an alternative to using an insulin pump or multiple daily injections (MDI) for insulin delivery. TI has a more rapid...
Tag: <span>type 1 diabetes</span>
Post
Health care professionals need better support to diagnose and treat type 1 diabetes eating disorders, study indicates
by University of Surrey Credit: Unsplash/CC0 Public Domain Disordered eating in people living with type 1 diabetes is often referred to as T1DE. Diabulimia is one example of T1DE, a dangerous eating disorder which involves deliberate misuse of insulin for weight loss, leading to severe health problems and even death. New research from the University of...
Post
Double Diabetes: The Silent Threat Hiding in Type 1 Patients
Dr Doris Maugg March 05, 2025 469 Patients with type 1 diabetes (T1D) who have risk factors such as obesity and hypertension can develop insulin resistance over time, a characteristic typically associated with type 2 diabetes (T2D). This condition, known as double diabetes, combines the characteristics of T1D and T2D. “About a quarter of patients...
Post
Islet transplantation with blood vessel cells shows promise to treat type 1 diabetes
by Weill Cornell Medical College A stained graft which was retrieved six weeks after islet and reprogrammed vascular endothelial cell (R-VEC) co-transplantation. The white islet, revealed by insulin staining, is vascularized by green blood vessels derived from co-transplanted R-VECs, which are connected to host blood vessels (red). Credit: Dr. Ge Li Adding engineered human blood vessel-forming...
Post
Guidelines call for widespread Type 1 diabetes screening in children
by Bill Levesque, University of Florida Stages of type 1 diabetes. Credit: Hormone Research in Paediatrics (2024). DOI: 10.1159/000543035 A University of Florida Health physician-scientist led an international team of Type 1 diabetes experts who recently developed new treatment guidelines emphasizing wider screening for the disease among children and adolescents in the general population before symptoms arise. That...
Post
Semaglutide can also be beneficial to people with type 1 diabetes, clinical trial finds
by McGill University Credit: Unsplash/CC0 Public Domain Semaglutide (known by its brand name Ozempic) has gained widespread attention for its weight-loss benefits, but is officially approved for managing type 2 diabetes. While there is currently limited data on its risks and benefits for those with type 1 diabetes, new research offers promising insights. A new study...
Post
Bioengineering strategy uses immune-protected beta cell transplant to advance type 1 diabetes care
by Shawn Oberrath, Medical University of South Carolina Credit: Cell Reports (2024). DOI: 10.1016/j.celrep.2024.114994 Regenerative medicine holds the extraordinary promise that future patients in need of new cells, tissues or organs will no longer have to rely on donors. Organ shortages and cell type mismatches will become past problems, replaced by safe, on-demand options for anyone who needs...
Post
Transplanting insulin-making cells to treat Type 1 diabetes is challenging. Stem cells offer a potential improvement
by Vinny Negi, The Conversation Credit: Pixabay/CC0 Public Domain Diabetes develops when the body fails to manage its blood glucose levels. One form of diabetes causes the body to not respond to insulin at all. Called Type 1 diabetes, or T1D, this autoimmune disease happens when the body’s defense system mistakes its own insulin-producing cells as foreign...
Post
Off-label glucose-lowering drugs may put type 1 diabetes patients at risk
by Justin Jackson , Medical Xpress Credit: Unsplash/CC0 Public Domain A collaboration of researchers led by Emory University Rollins School of Public Health, Atlanta, is urging caution when prescribing off-label glucose-lowering drugs to individuals with type 1 diabetes (T1D). Both glucagon-like peptide-1 receptor agonists (GLP-1RA) and sodium-glucose cotransporter 2 (SGLT2) inhibitors have shown significant benefits...
Post
Stem cell therapy reverses type 1 diabetes in world first
Credit: Cell (2024). DOI: 10.1016/j.cell.2024.09.004 A groundbreaking discovery has recently brought hope to millions of people living with type 1 diabetes around the world. In a world first, scientists have successfully used stem cell therapy to reverse type 1 diabetes in a woman. This achievement is being hailed as a major medical breakthrough, as it offers a potential cure...